Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2016

View Archived Issues

Sun Biopharma reports progress on phase I trial of SBP-101

CASI Pharmaceuticals' phase II trial of ENMD-2076 meets stage I endpoint

Boehringer Ingelheim Pharma patents aldosterone synthase inhibitors

Anthera Pharmaceuticals says phase III SOLUTION trial will continue

Genentech and Constellation Pharmaceuticals disclose TAF1 inhibitors

Genentech and Constellation Pharmaceuticals present KDM1A inhibitors

Neurocrine Biosciences describes antiepileptic agents

Cancer Research UK launches phase I/II trial to evaluate guadecitabine in resistant bladder cancer

Janssen Research & Development gains FDA breakthrough designation for esketamine

NSAID class may be repurposed to treat Alzheimer's disease

Phase III AFFINITY trial of custirsen does not meet the primary endpoint

Vyriad signs license collaboration with Imanis Life Sciences

Xycrobe Therapeutics enters research agreement with Johnson & Johnson

Promising phase III topline results for RBP-6000 monthly depot to treat opioid use disorder

Trek Therapeutics in-licenses rights to Medivir's MIV-802

Evgen receives CTA in U.K. for phase II breast cancer trial of SFX-01

Thalidomide reduces VEGF levels in trial in patients with POEMS syndrome

Eiger initiates phase II trial of pegylated interferon lambda for chronic HDV infection

Oncoceutics Pharmaceuticals wins FDA orphan grant for phase II trial of ONC-201

Japan Tobacco seeks Japanese approval for emtricitabine/tenofovir alafenamide

Study adds to complexity of nasal flu vaccine picture

Pilot study explores use of high-dose thyroid hormone to promote remyelination in MS

Phase II trial explores use of abituzumab in systemic sclerosis-associated interstitial lung disease

Karus Therapeutics initiates phase I trial of KA-2237 in B-cell lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...